BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7356037)

  • 1. Preservation of ischemic myocardium by pinane thromboxane A2.
    Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
    Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog.
    Smith EF; Lefer AM; Aharony D; Smith JB; Magolda RL; Claremon D; Nicolaou KC
    Prostaglandins; 1981 Mar; 21(3):443-56. PubMed ID: 7232768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats.
    Smith EF; Lefer AM; Smith JB
    Can J Physiol Pharmacol; 1980 Mar; 58(3):294-300. PubMed ID: 7378931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor.
    Burke SE; DiCola G; Lefer AM
    J Cardiovasc Pharmacol; 1983; 5(5):842-7. PubMed ID: 6195474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
    Brezinski ME; Yanagisawa A; Darius H; Lefer AM
    Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of a novel thromboxane analog in lethal traumatic shock.
    Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
    Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives.
    Roth DM; Lefer AM; Smith JB; Nicolaou KC
    Prostaglandins Leukot Med; 1982 Nov; 9(5):503-9. PubMed ID: 6960376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia.
    Smith EF; Carrow BA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):413-33. PubMed ID: 7403657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids.
    Lefer AM; Burke SE; Lepran I
    Can J Physiol Pharmacol; 1984 Dec; 62(12):1487-91. PubMed ID: 6241500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
    Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
    Ohnishi H; Kosuzume H; Hayashi Y; Yamaguchi K; Suzuki Y; Itoh R
    Prostaglandins Med; 1981 Mar; 6(3):269-81. PubMed ID: 6894333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle.
    Smith EF; Lefer AM; Smith JB; Nicolaou KC
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):130-4. PubMed ID: 6276789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
    Bhat AM; Sacks H; Osborne JA; Lefer AM
    Am Heart J; 1989 Apr; 117(4):799-803. PubMed ID: 2929397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death.
    Burke SE; Roth DM; Lefer AM
    Thromb Res; 1983 Mar; 29(5):473-88. PubMed ID: 6857596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium.
    Lefer AM; Mentley R; Sun JZ
    Circ Res; 1988 Sep; 63(3):621-7. PubMed ID: 3136950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE; Lefer DJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thromboxane A2 injection on the rabbit coronary artery. I. Physiologic effects in healthy animals.
    Sasagawa S; Moriya K; Sugaya Y; Mitani J; Yajima M
    Exp Mol Pathol; 1982 Aug; 37(1):111-7. PubMed ID: 7117494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.